BRIEF-Genmab announces European regulatory submission for daratumumab

* Genmab announces European regulatory submission for daratumumab in relapsed multiple myeloma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.